Showing results (1481-1490 of 1,619) with videos related to
Sort By:
Pageof 162
Cancer|September 16, 2023
Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumorsSamuel A Funt, Andrea Knezevic, Kaamilah Wilson, et al.Cancer Medicine|September 6, 2025
Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer SurvivorsSwetha Nakshatri, Paul C Dinh, Lawrence H Einhorn, et al.Clinical Genitourinary Cancer|June 2, 2019
Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment OutcomesYasser Ged, Ying-Bei Chen, Andrea Knezevic, et al.The Journal of Dermatological Treatment|December 10, 2024
Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52Steven R Feldman, Joanna Narbutt, Giampiero Girolomoni, et al.Journal of the American Academy of Dermatology|April 30, 2024
A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasisSteven R Feldman, Joanna Narbutt, Giampiero Girolomoni, et al.Health Education & Behavior : the Official Publication of the Society for Public Health Education|August 6, 1999
Stages of change for increasing fruit and vegetable consumption among adults and young adults participating in the national 5-a-Day for Better Health community studiesM K Campbell, K D Reynolds, S Havas, et al.The Oncologist|August 11, 2019
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trialDaniel J George, Colin Hessel, Susan Halabi, et al.Journal of the American Academy of Dermatology|April 22, 2008
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsAlan Menter, Alice Gottlieb, Steven R Feldman, et al.Journal of the American Academy of Dermatology|February 23, 2016
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension studyKim A Papp, James G Krueger, Steven R Feldman, et al.Environmental Science & Technology|July 21, 2017
Elliptic Cylinder Airborne Sampling and Geostatistical Mass Balance Approach for Quantifying Local Greenhouse Gas EmissionsJovan M Tadić, Anna M Michalak, Laura Iraci, et al.Pageof 162